Gautam Shenoy, Ph.D.

Gautam is an immunologist with expertise in immuno-oncology and cancer immunotherapy, and is focused on in vivo pharmacology studies at Strand as part of their immuno-oncology program. Prior to joining Strand, Gautam was a research scientist at University at Buffalo, where he was involved in translational research to identify and target immunosuppressive extracellular vesicles called exosomes in the microenvironment of solid tumors in order to rescue T cell function and ultimately suppress tumor growth. Gautam has also been involved in designing and validating novel patient-derived xenograft models for preclinically testing the efficacy of immune-based cancer therapies. He earned his Ph.D. from National Institute of Immunology in New Delhi, India, where he worked on identifying mechanisms that regulate death and differentiation in plasma cells. Gautam also has an M.Sc. In Biotechnology from Bangalore University and a B.Sc. in Microbiology & Biochemistry from St. Xavier’s College, University of Mumbai in India. He has authored multiple publications in peer-reviewed journals, including Nature Immunology, Journal for Immunotherapy of Cancer (JITC), Cancer Immunology Research and Journal of Immunology. He has also peer-reviewed over 120 research papers submitted for consideration of publication across 20 different journals in the fields of immunology and cancer research and serves on the editorial board of one of these journals.